Saudi Arabia In-Vitro Diagnostics Market (By Segment, Application, Product, End-user), Market Share, Key Company Profiles, Revenue, Recent Developments - Forecast to 2030

The Saudi Arabia in-vitro diagnostics market was valued at USD 734.7 Million in 2024, and the market is predicted to reach USD 932.3 Million by 2030. The high burden of chronic diseases such as diabetes, cancer, cardiovascular diseases, and infectious diseases have led to considerable demand for in-vitro diagnostics in Saudi Arabia. Owing to the vast opportunities in this region, key players have been coming up with market development strategies to leverage it. For instance, in June 2021, G42 Healthcare and Seegene Inc. signed a Memorandum of Understanding (MoU) to offer fully equipped mobile diagnostics and testing laboratories across the Middle East and North African region, including Saudi Arabia. The growth is further supported by the government's plan to invest over USD 65 Billion to enhance healthcare infrastructure and privatize 290 hospitals and 2,300 primary health centers by 2030.

Key Highlights of the Report

On Segment basis, Immunoassay and Clinical Chemistry are the leading segment of the Saudi Arabia IVD market. In 2024, Immunoassay and Clinical Chemistry together accounted for over 50 percent share of the total market. Both these segments are likely to maintain their dominant position over the forecast period.

Molecular Diagnostics is one of the fastest growing segments of the Saudi Arabia IVD market.

The growth of the hematology market is attributed to the increasing incidences of blood disorders and other diseases, increasing adoption of automated hematology instruments by diagnostic laboratories, and the emergence of high throughput hematology analyzers.

Based on application, Infectious diseases and Diabetes are the leading segment of the Saudi Arabia IVD market.

Autoimmune diseases and Nephrology are competing closely to grab maximum share of the pie.

Increasing obesity levels in Saudi Arabia coupled with growing requirements of aging patients at both facility-based geriatric care as well as home-based managed care facilities is also expected to drive demand for various diabetes diagnostic devices and systems.

In terms of product segment, Reagents held largest share of the Saudi Arabia IVD market in 2024, and is expected to remain dominant over the forecast period, since reagents are a vital part of every in-vitro diagnostic test.

The instruments segment was responsible for second highest share of the Saudi Arabia IVD market in 2024. The introduction of advanced instruments offers an excellent avenue for the segment's growth.

The Software and Services product segment contributed least share to the Saudi Arabia IVD market in 2024.

On the basis of End-users, Government Labs & Hospitals accounted for maximum share of the Saudi Arabia IVD market in 2024, owing to the large volume of diagnostic tests carried out in hospitals and the rising volumes of Class II and Class III in-vitro diagnostics medical devices that are being readily used for diagnostic testing.

In 2024, Private Labs & Hospitals contributed nearly a quarter share to the overall Saudi Arabia IVD market. The Saudi Arabia’s government initiatives, such as introducing public-private participation healthcare models to achieve the Vision 2030 target of privatization of 290 hospitals and 2,300 primary health centers by 2030.

Apelo Consulting report titled “Saudi Arabia In-Vitro Diagnostics Market (By Segment, Application, Product, End-user), Market Share, Key Company Profiles, Revenue, Recent Developments - Forecast to 2030” provides a comprehensive analysis of the Saudi Arabia In-Vitro Diagnostics (IVD) Market.

This 112 Pages report with 46 Figures and 8 Tables has been analyzed from 9 View Points:

1) Saudi Arabia In-Vitro Diagnostics Market and Forecast (2021 - 2030)

2) Saudi Arabia In-Vitro Diagnostics Market Share and Forecast (2021 - 2030)

3) By Segment - Saudi Arabia In-Vitro Diagnostics Market & Forecast (2021 - 2030)

4) By Application - Saudi Arabia In-Vitro Diagnostics Market & Forecast (2021 - 2030)

5) By Product - Saudi Arabia In-Vitro Diagnostics Market & Forecast (2021 - 2030)

6) By End User - Saudi Arabia In-Vitro Diagnostics Market & Forecast (2021 - 2030)

7) Saudi Arabia In-Vitro Diagnostics Market - Key Company Profiles

8) In-Vitro Diagnostics (IVD) Market - Recent Developments

9) Saudi Arabia In-Vitro Diagnostics - Market Dynamics

By Segment - Saudi Arabia IVD Market and Forecast

1. Immunoassay

2. Clinical Chemistry

3. Hematology

4. Coagulation/Hemostasis

5. Microbiology

6. Molecular Diagnostic

7. Self-Monitoring of Blood Glucose (SMBG)

8. Point of Care Testing (POCT)

9. Others

By Application - Saudi Arabia IVD Market and Forecast

1. Infectious Diseases

2. Cardiovascular Diseases

3. Diabetes

4. Oncology

5. Nephrology

6. Autoimmune Diseases

7. Others

By Product - Saudi Arabia IVD Market and Forecast

Reagents

Instruments

Software and Services

By End User - Saudi Arabia IVD Market and Forecast

Government Labs & Hospitals

Private Labs & Hospitals

Others

Saudi Arabia IVD Market - Key Company Profiles

1. Roche

2. Abbott

3. Sysmex Corporation

4. Danaher Corporation

5. Thermo Fischer Scientific Inc.

6. Siemens Healthineers

7. Biomerieux SA

8. Bio-Rad Laboratories, Inc

9. Becton Dickinson and Company

10. Nihon Kohden Corporation

Data Source

Apelo Consulting employs comprehensive primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by Apelo Consulting dedicated team of qualified professionals with deep industry experience and expertise. Show more